Latest: Zensar Technologies Ltd Q2 FY27 results →All Q1 FY27 results →
ZT

Zensar Technologies Ltd

Q1 FY27

Zensar Technologies Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹508
Market cap₹11.6K Cr
P/E14.5
Updated16 Oct 2026
Read3 min read

Zensar Technologies Ltd Q1 FY27 key numbers

Revenue
Q2 FY '27 is anticipated to be better than Q1, with ongoing ramp-up of a large $210 million deal contributing to future growth.

As stated in Zensar Technologies Ltd's Q1 FY27 earnings call transcript · published 25 Aug 2026. Reported figures, not investment advice.

The short version

Revenue growth is expected to continue with a mixed demand environment but broad-based volume growth, reinforcing confidence in the current strategy. Revenue growth is expected to maintain trajectory with Q2 anticipated to be better than Q1, driven by ramp-up of large deals and broad-based volume growth.

From Zensar Technologies Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

Slow growth
  • Revenue growth is expected to continue with a mixed demand environment but broad-based volume growth, reinforcing confidence in the current strategy.
  • Q2 FY '27 is anticipated to be better than Q1, with ongoing ramp-up of a large $210 million deal contributing to future growth.
  • The large deal's full revenue impact is expected to appear in Q3 and Q4 FY '27.
  • The company aims to maintain a book-to-bill ratio around 0.9 to 1.1x of projected revenue, factoring in sporadic mega deals.
  • New business from existing clients and net new clients is at an all-time high, supporting healthy pipeline prospects.
  • Sales force investments and revamping go-to-market strategies aligned with AI to accelerate revenue growth.

2 more points from Zensar Technologies Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Zensar Technologies Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Zensar Technologies is actively looking to deploy its healthy cash reserves.
  • The company focuses on acquiring scaled assets rather than tuck-in acquisitions.
  • Target assets are in the revenue range of $150 million to over $200 million.

2 more points from Zensar Technologies Ltd's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Zensar Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Order book flat
  • Order book for Q1 FY '27 stood at $149.2 million.
  • Fresh order intake in Q1 was broadly $149 million, marking a multi-quarter low.
  • Despite lower order intake, the proportion of new business from existing and net new clients was at an all-time high.
  • Q1 is usually seasonally weak for renewals, which mostly happen in Q3 or Q4, so management is not overly concerned.
  • The large mega deal booked nearly $403 million in the previous quarter, impacting book-to-bill ratios in subsequent quarters.

2 more points from Zensar Technologies Ltd's call on order book

Create a free account to keep reading this call

What the Q1 FY27 call signalled

1 of 4 strong

RevenueSlow growth
MarginMargins steady
CapexCapex planned
Order bookOrder book flat

Zensar Technologies Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.4K Cr, net profit ₹211 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in IT - Software this season

  • Delaplex (Q1 FY27)

    H2 FY26 total income (quarterly equivalent): ₹340.4 Mn vs ₹328.4 Mn in H2 FY25, a 3.66% YoY increase. Key investor presentation takeaways from Delaplex Ltd's Q1

  • Xelpmoc Design and Tech Ltd (Q1 FY27)

    Q1 FY27 Revenue from Operations: Rs 9.6 million, up 22.5% YoY from Rs 7.8 million in Q1 FY26 (Page 27). Key investor presentation takeaways from Xelpmoc Design'

  • Cybertech Systems & Software Ltd (Q1 FY27)

    Total Revenue: ₹766.3 million, up 17.5% YoY (Page 3, 15, 19) . Key investor presentation takeaways from Cybertech Systems & Software Ltd's Q1 FY27 investor pres

  • Workmates Core2 (Q1 FY27)

    FY26 total revenue: ₹143 Cr (Page 10) . Key concall takeaways from Workmates Core2cloud Solution Ltd's Q1 FY27 earnings call — and how it ranks against sector…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Zensar Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Zensar Technologies Ltd Q1 FY27 results?

Revenue growth is expected to continue with a mixed demand environment but broad-based volume growth, reinforcing confidence in the current strategy. Revenue growth is expected to maintain trajectory with Q2 anticipated to be better than Q1, driven by ramp-up of large deals and broad-based volume growth.

What is Zensar Technologies Ltd share price analysis?

Zensar Technologies Ltd currently shows a neutral. The stock trades at a P/E of 14.5 with a market cap of ₹11,555 Cr. Investors should review the full earnings analysis for detailed insights.

Is Zensar Technologies Ltd planning capital expenditure?

Zensar Technologies is actively looking to deploy its healthy cash reserves.

Keep Zensar Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.